Cell therapy company SQZ Biotechnologies has landed an in-house veteran for the life sciences industry to serve as the firm’s first general counsel, just a few weeks after poaching a new chief financial officer from pharmaceutical giant Merck & Co. Inc.
Larry Knopf takes control of the legal department at SQZ after having held in-house leadership roles at medical device makers Boston Scientific Corp. and HeartWare International Inc. He spent the past two years as a legal consultant at an eponymous firm.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]